Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Hepcidin is a potential regulator of iron status in chronic kidney disease.

Tsuchiya K, Nitta K.

Ther Apher Dial. 2013 Feb;17(1):1-8. doi: 10.1111/1744-9987.12001. Epub 2012 Dec 16. Review.

PMID:
23379486
2.

Hepcidin: clinical utility as a diagnostic tool and therapeutic target.

Coyne DW.

Kidney Int. 2011 Aug;80(3):240-4. doi: 10.1038/ki.2011.141. Epub 2011 Jun 15. Review.

3.

Hepcidin for clinicians.

Young B, Zaritsky J.

Clin J Am Soc Nephrol. 2009 Aug;4(8):1384-7. doi: 10.2215/CJN.02190309. Epub 2009 Jun 25. Review.

4.

Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist.

Atkinson MA, White CT.

Pediatr Nephrol. 2012 Jan;27(1):33-40. doi: 10.1007/s00467-011-1832-y. Epub 2011 Mar 13. Review.

PMID:
21400189
5.

Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?

Nakanishi T, Kuragano T, Kaibe S, Nagasawa Y, Hasuike Y.

Clin Exp Nephrol. 2012 Dec;16(6):819-26. doi: 10.1007/s10157-012-0694-3. Epub 2012 Sep 29. Review.

6.

The role of hepcidin in iron homeostasis and anemia in hemodialysis patients.

Eleftheriadis T, Liakopoulos V, Antoniadi G, Kartsios C, Stefanidis I.

Semin Dial. 2009 Jan-Feb;22(1):70-7. doi: 10.1111/j.1525-139X.2008.00532.x. Review.

PMID:
19250447
7.

Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.

Uehata T, Tomosugi N, Shoji T, Sakaguchi Y, Suzuki A, Kaneko T, Okada N, Yamamoto R, Nagasawa Y, Kato K, Isaka Y, Rakugi H, Tsubakihara Y.

Nephrol Dial Transplant. 2012 Mar;27(3):1076-83. doi: 10.1093/ndt/gfr431. Epub 2011 Jul 28.

PMID:
21799206
8.

Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney disease.

Niihata K, Tomosugi N, Uehata T, Shoji T, Mitsumoto K, Shimizu M, Kawabata H, Sakaguchi Y, Suzuki A, Hayashi T, Okada N, Isaka Y, Rakugi H, Tsubakihara Y.

Nephrol Dial Transplant. 2012 Dec;27(12):4378-85; discussion 4384-5. doi: 10.1093/ndt/gfs322. Epub 2012 Jul 24.

PMID:
22833619
9.

Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.

Shinzato T, Abe K, Furusu A, Harada T, Shinzato K, Miyazaki M, Kohno S.

Med Sci Monit. 2008 Sep;14(9):CR431-7.

PMID:
18758412
10.

Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.

Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G.

Blood. 2009 May 21;113(21):5277-86. doi: 10.1182/blood-2008-12-195651. Epub 2009 Mar 17.

11.

Diagnostic potential of hepcidin testing in pediatrics.

Cangemi G, Pistorio A, Miano M, Gattorno M, Acquila M, Bicocchi MP, Gastaldi R, Riccardi F, Gatti C, Fioredda F, Calvillo M, Melioli G, Martini A, Dufour C.

Eur J Haematol. 2013 Apr;90(4):323-30. doi: 10.1111/ejh.12081. Epub 2013 Feb 26.

PMID:
23438060
12.

Hepcidin and disordered mineral metabolism in chronic kidney disease.

Carvalho C, Isakova T, Collerone G, Olbina G, Wolf M, Westerman M, GutiƩrrez OM.

Clin Nephrol. 2011 Aug;76(2):90-8.

PMID:
21762639
13.

Liver iron concentrations and urinary hepcidin in beta-thalassemia.

Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, Nemeth E.

Haematologica. 2007 May;92(5):583-8.

14.

[Iron, hepcidin and chronic kidney disease].

Fievet P, Brazier F.

Nephrol Ther. 2011 Apr;7(2):86-91. doi: 10.1016/j.nephro.2010.10.011. Epub 2010 Dec 24. French.

PMID:
21186144
15.

Hepcidin in anemia and inflammation in chronic kidney disease.

Malyszko J, Mysliwiec M.

Kidney Blood Press Res. 2007;30(1):15-30. Epub 2007 Jan 11. Review.

16.

Renal anemia of inflammation: the name is self-explanatory.

Yilmaz MI, Solak Y, Covic A, Goldsmith D, Kanbay M.

Blood Purif. 2011;32(3):220-5. doi: 10.1159/000328037. Epub 2011 Aug 9. Review.

17.

Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin.

Przybylowski P, Malyszko JS, Macdougall IC, Malyszko J.

Transplant Proc. 2013 Jan-Feb;45(1):387-90. doi: 10.1016/j.transproceed.2012.02.040.

PMID:
23375326
18.

Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo.

Theurl I, Schroll A, Nairz M, Seifert M, Theurl M, Sonnweber T, Kulaksiz H, Weiss G.

Haematologica. 2011 Dec;96(12):1761-9. doi: 10.3324/haematol.2011.048926. Epub 2011 Aug 22.

19.

The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis.

Pelusi S, Girelli D, Rametta R, Campostrini N, Alfieri C, Traglia M, Dongiovanni P, Como G, Toniolo D, Camaschella C, Messa P, Fargion S, Valenti L.

BMC Nephrol. 2013 Feb 22;14:48. doi: 10.1186/1471-2369-14-48.

20.

Iron-deficiency anemia secondary to mutations in genes controlling hepcidin.

Cau M, Melis MA, Congiu R, Galanello R.

Expert Rev Hematol. 2010 Apr;3(2):205-16. doi: 10.1586/ehm.10.2. Review.

PMID:
21083463

Supplemental Content

Support Center